XML 34 R15.htm IDEA: XBRL DOCUMENT
v3.20.2

Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests | 6 Months Ended
--- | ---
Jun. 28, 2020
Equity [Abstract] |
Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests | Accumulated Other Comprehensive Loss, Excluding Noncontrolling Interests
The following table provides the changes, net of tax, in Accumulated other comprehensive loss:
|  | Net Unrealized Gains/(Losses) |  | Benefit Plans |  |
(MILLIONS OF DOLLARS) |  | Foreign Currency Translation Adjustments |  |  | Derivative Financial Instruments |  |  | Available-For-Sale Securities |  |  | Actuarial Gains/(Losses) |  |  | Prior Service (Costs)/Credits and Other |  |  | Accumulated Other Comprehensive Income/(Loss) |
Balance, December 31, 2019 |  | $ | (5,952 | ) |  | $ | 20 |  |  | $ | (35 | ) |  | $ | (6,257 | ) |  | $ | 584 |  |  | $ | (11,640 | )
Other comprehensive income/(loss)(a) |  | (1,310 | ) |  | (353 | ) |  | 44 |  |  | 79 |  |  | (65 | ) |  | (1,605 | )
Balance, June 28, 2020 |  | $ | (7,262 | ) |  | $ | (333 | ) |  | $ | 9 |  |  | $ | (6,178 | ) |  | $ | 518 |  |  | $ | (13,246 | )
(a) Amounts do not include foreign currency translation adjustments attributable to noncontrolling interests of $12 million loss for the first six months of 2020. Includes after-tax losses of approximately $902 million related to foreign currency translation adjustments and the impact of our net investment hedging program, both attributable to our equity method investment in GSK Consumer Healthcare (see Note 2B), and losses from the weakening of certain major currencies against the U.S. dollar. These losses were partially offset by the results of our net investment hedging program.

X
- Definition The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -URI http://asc.fasb.org/topic&trid=2134417 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(21)) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(23)) -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(19)) -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 + Details
Name: | us-gaap_ComprehensiveIncomeNoteTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration